Current Neuro-Oncology
Volume
4 Number 3
31 March 2002
Home > Publications > Current Neuro-Oncology > Volume 4, Year 2002 > Number 3, 31 March
Didenko VV, Ngo HN, Minchew C,
Baskin DS.
Apoptosis
of T lymphocytes invading glioblastomas multiforme: a possible
tumor defense mechanism.
J
Neurosurg. 2002 Mar;96(3):580-4∟.
doi: 10.3171/jns.2002.96.3.0580∟.
PMID: 11883844∟.
Observational study. ˍ
Peters TR, Jennings MT, Crowe JE
Jr.
Pneumocystis
carinii pneumonia in a girl with a midbrain glioma.
Pediatr
Hematol Oncol. 2002 Mar;19(2):141-3∟.
doi: 10.1080/08880010252825731∟.
PMID: 11881789∟.
Case report. ˍ
Groves MD, Puduvalli VK, Hess KR,
Jaeckle KA, Peterson P, Yung WK, Levin VA.
Phase
II trial of temozolomide plus the matrix metalloproteinase
inhibitor, marimastat, in recurrent and progressive glioblastoma
multiforme.
J
Clin Oncol. 2002 Mar 1;20(5):1383-8∟.
doi: 10.1200/JCO.2002.20.5.1383∟.
PMID: 11870183∟.
Interventional study. ˍ
Reardon DA, Akabani G, Coleman RE,
Friedman AH, Friedman HS, Herndon JE 2nd, Cokgor
I, McLendon RE, Pegram CN, Provenzale JM, Quinn JA, Rich JN,
Regalado LV, Sampson JH,
Shafman TD, Wikstrand CJ, Wong TZ, Zhao XG, Zalutsky MR, Bigner
DD.
Phase
II trial of murine (131)I-labeled antitenascin monoclonal antibody
81C6 administered
into surgically created resection cavities of patients with newly
diagnosed
malignant gliomas.
J
Clin Oncol. 2002 Mar 1;20(5):1389-97∟.
doi: 10.1200/JCO.2002.20.5.1389∟.
PMID: 11870184∟.
Interventional study. ˍ
*
Stupp R, Dietrich PY, Ostermann
Kraljevic S, Pica A, Maillard I, Maeder P, Meuli R, Janzer R,
Pizzolato G, Miralbell R, Porchet F, Regli L, de Tribolet N,
Mirimanoff RO, Leyvraz S.
Promising
survival for patients with newly diagnosed glioblastoma multiforme
treated with concomitant radiation plus temozolomide followed by
adjuvant temozolomide.
J
Clin Oncol. 2002 Mar 1;20(5):1375-82∟.
doi: 10.1200/JCO.2002.20.5.1375∟.
PMID: 11870182∟.
Interventional study. ˍ
Chan JL, Lee SW, Fraass BA,
Normolle DP, Greenberg HS, Junck LR, Gebarski SS, Sandler
HM.
Survival
and failure patterns of high-grade gliomas after three-dimensional
conformal radiotherapy.
J
Clin Oncol. 2002 Mar 15;20(6):1635-42∟.
doi: 10.1200/JCO.2002.20.6.1635∟.
PMID: 11896114∟.
Observational study. ˍ
Raymond E, Campone M, Stupp R,
Menten J, Chollet P, Lesimple T, Fety-Deporte R, Lacombe D,
Paoletti X, Fumoleau P; EORTC Early Clinical Studies Group (ECSG);
Brain Tumor Studies Group (BTSG); New Drug Development Program
(NDDP).
Multicentre phase II and
pharmacokinetic study of RFS2000 (9-nitro-camptothecin)
administered orally 5 days a week in
patients with glioblastoma multiforme.
Eur J Cancer.
2002 Mar 15;38(10):1348-50∟.
doi: 10.1016/s0959-8049(02)00070-9∟.
PMID: 12091065∟.
Interventional study. ˍ
Voges J, Weber F, Reszka R, Sturm V, Jacobs A, Heiss WD, Wiestler
O, Kapp JF.
Clinical protocol.
Liposomal gene therapy with the herpes simplex thymidine kinase
gene/ganciclovir system for the treatment of glioblastoma
multiforme.
Hum Gene Ther. 2002 Mar 20;13(5):675-85∟.
doi: 10.1089/10430340252837260∟.
PMID: 11916490∟.
Interventional study protocol. ˍ
Chhieng DC, Elgert P, Cohen JM,
Jhala NC, Cangiarella JF.
Cytology
of primary central nervous system neoplasms in cerebrospinal fluid
specimens.
Diagn
Cytopathol. 2002 Mar 28;26(4):209-12∟.
doi: 10.1002/dc.10013∟.
PMID: 11933264∟.
Observational study. ˍ
Mesiwala AH, Loeser JD.
Visual
pathway glioma.
Pediatr
Neurosurg. 2002 Mar 28;36(3):161∟.
doi: 10.1159/000048373∟.
PMID: 11919452∟.
Case report. ˍ
Bradbury J.
Brain
tumour-JC virus link strengthened but not proven.
Lancet
Infect Dis. 2002 Mar 31;2(4):201∟.
doi: 10.1016/s1473-3099(02)00255-4∟.
PMID: 11937413∟.
Editorial perspective. ˍ